Benitec Biopharma

#7528

Rank

$411.09M

Marketcap

United States

Country

Leadership team

Mr. Bryan Dulhunty (Chief Financial Officer)

Dr. Jerel A. Banks M.D., Ph.D. (Exec. Chairman & CEO)

Ms. Megan Joan Boston BComm, CA, Dip., GAICD (Exec. Director)

Products/ Services

Biotechnology, Genetics, Health Diagnostics, Medical, Therapeutics

Headquarters

Hayward, California, United States

Established

2001

Company Registration

SEC CIK number: 0001808898

Traded as

BNTC

Social Media

URL

https://benitec.com

Overview

Location

Recognition and Award

References

Summary

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.

History

Benitec Biopharma was founded in 1996 as Australia’s first biotechnology start-up. It is now one of the largest and most successful fully integrated biopharmaceutical companies in the world, focused on gene silencing therapies for the treatment of devastating diseases with high unmet medical need. Benitec Biopharma has operations in Australia, United States, Europe, and Taiwan and is committed to improving health outcomes for patients.

Mission

Benitec Biopharma’s mission is to develop life-saving therapies to treat debilitating diseases with high unmet medical need, while empowering patients and their families.

Vision

Benitec Biopharma’s vision is to be the leader in gene silencing therapies and innovative therapeutic products, focused on meeting the needs of patients and healthcare professionals.

Key Team

Dr. Michael Graham (Head of Discovery & Founding Scientist)

Dr. Claudia Kloth (Sr. VP of Manufacturing)

Dr. Craig Lewis (Chief Medical Adviser)

Recognition and Awards

Benitec Biopharma has won numerous awards, including the AstraZeneca/Biotechnology Industry Association Innovation Award and the Biotech Industry Award. Additionally, Benitec Biopharma has been recognized as one of the world’s top 5 Biotechs by FierceBiotech.